BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION
Clinical trials for BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION trials appear
Sign up with your email to follow new studies for BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood test could spot breast cancer early, saving lives
Diagnosis Recruiting nowThis study is testing a new blood test called Oncoliq to see if it can find breast cancer early. Researchers will collect blood from 300 women, some with breast cancer and some without, to check for tiny molecules called miRNAs that tumors release. The goal is to create a simple,…
Matched conditions: BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION
Sponsor: Oncoliq US Inc • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Could fewer heart scans be safer for breast cancer patients?
Knowledge-focused Recruiting nowThis pilot study tests whether a personalized approach to heart imaging can safely reduce the number of echocardiograms women with early-stage breast cancer need during HER2-targeted therapy. The goal is to avoid unnecessary tests while still catching any heart side effects early…
Matched conditions: BREAST CANCER WITH LOW TO INTERMEDIATE HER2 EXPRESSION
Phase: NA • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC